Limits...
Expression of Placental Neurotrophin-3 (NT-3) in Physiological Pregnancy, Preeclampsia and Chorioamnionitis.

Casciaro A, Arcuri F, Occhini R, Toti MS, De Felice C, Toti P - Clin Med Pathol (2009)

Bottom Line: They are involved in the regulation of morphogenesis and development of several tissues.The roles of Neurotrophin-3 in pregnancy are presently unknown.A regulatory function on placenta and foetal brain development and maternal inflammatory response may be hypothesized.

View Article: PubMed Central - PubMed

Affiliation: Department of Human Pathology and Oncology.

ABSTRACT
Neurotrophic factors are a group of proteins that act as paracrine and autocrine growth factors. They are involved in the regulation of morphogenesis and development of several tissues. The present study aims to evaluate, for the first time, the expression of Neurotrophin-3 in the human placenta during normal pregnancy and in preeclampsia and chorioamnionitis. Neurotrophin-3 mRNA, assessed by RT-PCR analysis in six term placentas, were observed in all the specimens examined. Neurotrophin-3 protein expression and tissue distribution was evaluated by immunohistochemistry in placenta samples from uncomplicated first trimester (n = 5) and term (n = 5) pregnancies as well as in specimens from preeclampsia (n = 5) and chorioamnionitis (n = 5). In first trimester specimens, strong immunoreactivity was present in villous stromal cells, in the cyto- and syncytiotrophoblast, in decidua cells and in endometrial glands. Third trimester specimens showed prominent immunostaining in cyto- and syncytiotrophoblast cells, in decidua cells and in the amniotic membranes. Villous stromal cells were weakly stained. Similar protein localization was observed in placentas with preeclampsia and chorioamnionitis. In the latter, however, positive villous stromal cells increased in number and in staining intensity when compared with controls and preeclampsia (p < 0.001). The roles of Neurotrophin-3 in pregnancy are presently unknown. A regulatory function on placenta and foetal brain development and maternal inflammatory response may be hypothesized.

No MeSH data available.


Related in: MedlinePlus

Reverse transcriptase—PCR analysis of NT-3 mRNA levels (A) in placental tissues. One μg of total RNA of six placenta specimens (lanes 1–6) was reverse transcribed and amplified in the presence of NT-3 (A) and Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) (B) primers. For each specimen a negative control, prepared by omitting the reverse transcriptase, was amplified and loaded onto the gel (A: unmarked lanes). Thirty cycles were run for each PCR. The size of the molecular weight makers (lanes M; bp) is indicated.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC2990238&req=5

f1-cpath-2009-009: Reverse transcriptase—PCR analysis of NT-3 mRNA levels (A) in placental tissues. One μg of total RNA of six placenta specimens (lanes 1–6) was reverse transcribed and amplified in the presence of NT-3 (A) and Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) (B) primers. For each specimen a negative control, prepared by omitting the reverse transcriptase, was amplified and loaded onto the gel (A: unmarked lanes). Thirty cycles were run for each PCR. The size of the molecular weight makers (lanes M; bp) is indicated.

Mentions: The expression of NT-3 in human placenta was first evaluated by RT-PCR analysis. One μg of total RNA extracted from term placenta (n = 6) was reverse transcribed and amplified in the presence of NT-3 primers. An intense band, corresponding in size to the NT-3 product, was obtained from the cDNA of all the specimens examined (Fig. 1). The identity of the NT-3 cDNA was confirmed by direct DNA sequencing. Lack of PCR products was observed in negative controls obtained by omitting the reverse transcriptase (Fig. 1).


Expression of Placental Neurotrophin-3 (NT-3) in Physiological Pregnancy, Preeclampsia and Chorioamnionitis.

Casciaro A, Arcuri F, Occhini R, Toti MS, De Felice C, Toti P - Clin Med Pathol (2009)

Reverse transcriptase—PCR analysis of NT-3 mRNA levels (A) in placental tissues. One μg of total RNA of six placenta specimens (lanes 1–6) was reverse transcribed and amplified in the presence of NT-3 (A) and Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) (B) primers. For each specimen a negative control, prepared by omitting the reverse transcriptase, was amplified and loaded onto the gel (A: unmarked lanes). Thirty cycles were run for each PCR. The size of the molecular weight makers (lanes M; bp) is indicated.
© Copyright Policy - open-access
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC2990238&req=5

f1-cpath-2009-009: Reverse transcriptase—PCR analysis of NT-3 mRNA levels (A) in placental tissues. One μg of total RNA of six placenta specimens (lanes 1–6) was reverse transcribed and amplified in the presence of NT-3 (A) and Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) (B) primers. For each specimen a negative control, prepared by omitting the reverse transcriptase, was amplified and loaded onto the gel (A: unmarked lanes). Thirty cycles were run for each PCR. The size of the molecular weight makers (lanes M; bp) is indicated.
Mentions: The expression of NT-3 in human placenta was first evaluated by RT-PCR analysis. One μg of total RNA extracted from term placenta (n = 6) was reverse transcribed and amplified in the presence of NT-3 primers. An intense band, corresponding in size to the NT-3 product, was obtained from the cDNA of all the specimens examined (Fig. 1). The identity of the NT-3 cDNA was confirmed by direct DNA sequencing. Lack of PCR products was observed in negative controls obtained by omitting the reverse transcriptase (Fig. 1).

Bottom Line: They are involved in the regulation of morphogenesis and development of several tissues.The roles of Neurotrophin-3 in pregnancy are presently unknown.A regulatory function on placenta and foetal brain development and maternal inflammatory response may be hypothesized.

View Article: PubMed Central - PubMed

Affiliation: Department of Human Pathology and Oncology.

ABSTRACT
Neurotrophic factors are a group of proteins that act as paracrine and autocrine growth factors. They are involved in the regulation of morphogenesis and development of several tissues. The present study aims to evaluate, for the first time, the expression of Neurotrophin-3 in the human placenta during normal pregnancy and in preeclampsia and chorioamnionitis. Neurotrophin-3 mRNA, assessed by RT-PCR analysis in six term placentas, were observed in all the specimens examined. Neurotrophin-3 protein expression and tissue distribution was evaluated by immunohistochemistry in placenta samples from uncomplicated first trimester (n = 5) and term (n = 5) pregnancies as well as in specimens from preeclampsia (n = 5) and chorioamnionitis (n = 5). In first trimester specimens, strong immunoreactivity was present in villous stromal cells, in the cyto- and syncytiotrophoblast, in decidua cells and in endometrial glands. Third trimester specimens showed prominent immunostaining in cyto- and syncytiotrophoblast cells, in decidua cells and in the amniotic membranes. Villous stromal cells were weakly stained. Similar protein localization was observed in placentas with preeclampsia and chorioamnionitis. In the latter, however, positive villous stromal cells increased in number and in staining intensity when compared with controls and preeclampsia (p < 0.001). The roles of Neurotrophin-3 in pregnancy are presently unknown. A regulatory function on placenta and foetal brain development and maternal inflammatory response may be hypothesized.

No MeSH data available.


Related in: MedlinePlus